Case report: Pembrolizumab plus Axitinib related hypothyroid myopathy in two kidney cancer patients

por Boutros, Andrea, Vera, Lara, Gatto, Federico, Fornarini, Giuseppe, Zanardi, Elisa
Publicado 2022

To switch or not to switch? A real-life experience using dexamethasone in combination with abiraterone

por Zanardi, Elisa, Soldato, Davide, Latocca, Maria Maddalena, Cattrini, Carlo, Boccardo, Francesco
Publicado 2019

Cardiac Metastasis from Prostate Cancer: A Case Study Underlying the Crucial Role of the PSMA PET/CT

por Gandini, Annalice, Bauckneht, Matteo, Sofia, Luca, Tomasello, Laura, Fornarini, Giuseppe, Zanardi, Elisa
Publicado 2023

Response to trabectedin in a patient with advanced synovial sarcoma with lung metastases

por Zanardi, Elisa, Maruzzo, Marco, Montesco, Maria C., Roma, Anna, Rastrelli, Marco, Basso, Umberto
Publicado 2014

Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer

por Cattrini, Carlo, Castro, Elena, Lozano, Rebeca, Zanardi, Elisa, Rubagotti, Alessandra, Boccardo, Francesco, Olmos, David
Publicado 2019

Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer

por Cattrini, Carlo, Barboro, Paola, Rubagotti, Alessandra, Zinoli, Linda, Zanardi, Elisa, Capaia, Matteo, Boccardo, Francesco
Publicado 2020

Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastat...

por Cattrini, Carlo, Rubagotti, Alessandra, Zinoli, Linda, Cerbone, Luigi, Zanardi, Elisa, Capaia, Matteo, Barboro, Paola, Boccardo, Francesco
Publicado 2019

BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications

por Messina, Carlo, Cattrini, Carlo, Soldato, Davide, Vallome, Giacomo, Caffo, Orazio, Castro, Elena, Olmos, David, Boccardo, Francesco, Zanardi, Elisa
Publicado 2020

Prognostic Value of Preoperative Serum Levels of Periostin (PN) in Early Breast Cancer (BCa)

por Nuzzo, Pier Vitale, Rubagotti, Alessandra, Argellati, Francesca, Di Meglio, Antonio, Zanardi, Elisa, Zinoli, Linda, Comite, Paola, Mussap, Michele, Boccardo, Francesco
Publicado 2015

Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer

por Cattrini, Carlo, Soldato, Davide, Rubagotti, Alessandra, Zinoli, Linda, Zanardi, Elisa, Barboro, Paola, Messina, Carlo, Castro, Elena, Olmos, David, Boccardo, Francesco
Publicado 2020

Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovasc...

por Cavo, Alessia, Rubagotti, Alessandra, Zanardi, Elisa, Fabbroni, Chiara, Zinoli, Linda, Di Meglio, Antonio, Arboscello, Eleonora, Bellodi, Andrea, Spallarossa, Paolo, Cattrini, Carlo, Messina, Carlo, Boccardo, Francesco
Publicado 2018

Prognostic Value of Thyroid Hormone Ratio in Patients With Advanced Metastatic Renal Cell Carcinoma: Results From the Threefour Study (Meet-URO 14)

por Maruzzo, Marco, Verzoni, Elena, Vitale, Maria Giuseppa, Dionese, Michele, Buti, Sebastiano, Galli, Luca, Zivi, Andrea, Watutantrige-Fernando, Sara, Zielli, Teresa, Zanardi, Elisa, Sabbatini, Roberto, Basso, Umberto, Zagonel, Vittorina, Procopio, Giuseppe
Publicado 2021

Beyond the Prognostic Value of 2-[(18)F]FDG PET/CT in Prostate Cancer: A Case Series and Literature Review Focusing on the Diagnostic Value and Impact on Patient Management

por Borea, Roberto, Favero, Diletta, Miceli, Alberto, Donegani, Maria Isabella, Raffa, Stefano, Gandini, Annalice, Cremante, Malvina, Marini, Cecilia, Sambuceti, Gianmario, Zanardi, Elisa, Morbelli, Silvia, Fornarini, Giuseppe, Rebuzzi, Sara Elena, Bauckneht, Matteo
Publicado 2022

Immune Checkpoint Inhibitors in Advanced Prostate Cancer: Current Data and Future Perspectives

por Rebuzzi, Sara Elena, Rescigno, Pasquale, Catalano, Fabio, Mollica, Veronica, Vogl, Ursula Maria, Marandino, Laura, Massari, Francesco, Pereira Mestre, Ricardo, Zanardi, Elisa, Signori, Alessio, Buti, Sebastiano, Bauckneht, Matteo, Gillessen, Silke, Banna, Giuseppe Luigi, Fornarini, Giuseppe
Publicado 2022

Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients

por Cattrini, Carlo, Manfredi, Marcello, Barboro, Paola, Ghirimoldi, Marco, Mennitto, Alessia, Martini, Veronica, Battioni, Alessio, Le Van, Marco, Gobbato, Simone, Branni, Carmen, Ayed, Rahma Ben, Pinato, David James, Catalano, Fabio, Zanardi, Elisa, Boccardo, Francesco, Gennari, Alessandra
Publicado 2023

The Role of mpMRI in the Assessment of Prostate Cancer Recurrence Using the PI-RR System: Diagnostic Accuracy and Interobserver Agreement in Readers with Different Expertise

por Bergaglio, Chiara, Giasotto, Veronica, Marcenaro, Michela, Barra, Salvina, Turazzi, Marianna, Bauckneht, Matteo, Casaleggio, Alessandro, Sciabà, Francesca, Terrone, Carlo, Mantica, Guglielmo, Borghesi, Marco, Signori, Alessio, Spina, Bruno, Piol, Nataniele, Zanardi, Elisa, Fornarini, Giuseppe, Zawaideh, Jeries Paolo
Publicado 2023

Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223

por Bauckneht, Matteo, Capitanio, Selene, Donegani, Maria Isabella, Zanardi, Elisa, Miceli, Alberto, Murialdo, Roberto, Raffa, Stefano, Tomasello, Laura, Vitti, Martina, Cavo, Alessia, Catalano, Fabio, Mencoboni, Manlio, Ceppi, Marcello, Marini, Cecilia, Fornarini, Giuseppe, Boccardo, Francesco, Sambuceti, Gianmario, Morbelli, Silvia
Publicado 2019

Opportunistic skeletal muscle metrics as prognostic tools in metastatic castration-resistant prostate cancer patients candidates to receive Radium-223

por Bauckneht, Matteo, Lai, Rita, D’Amico, Francesca, Miceli, Alberto, Donegani, Maria Isabella, Campi, Cristina, Schenone, Daniela, Raffa, Stefano, Chiola, Silvia, Lanfranchi, Francesco, Rebuzzi, Sara Elena, Zanardi, Elisa, Cremante, Malvina, Marini, Cecilia, Fornarini, Giuseppe, Morbelli, Silvia, Piana, Michele, Sambuceti, Gianmario
Publicado 2022

Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for...

por Nuzzo, Pier Vitale, Pederzoli, Filippo, Saieva, Calogero, Zanardi, Elisa, Fotia, Giuseppe, Malgeri, Andrea, Rossetti, Sabrina, Valenca Bueno, Loana, Andrade, Livia Maria Q. S., Patrikidou, Anna, Mestre, Ricardo Pereira, Modesti, Mikol, Pignata, Sandro, Procopio, Giuseppe, Fornarini, Giuseppe, De Giorgi, Ugo, Russo, Antonio, Francini, Edoardo
Publicado 2023

Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prost...

por Nuzzo, Pier Vitale, Ravera, Francesco, Saieva, Calogero, Zanardi, Elisa, Fotia, Giuseppe, Malgeri, Andrea, Rossetti, Sabrina, Valença, Loana Bueno, Oliveira, Thiago Martins, Vauchier, Charles, Pereira Mestre, Ricardo, Modesti, Mikol, Patrikidou, Anna, Pignata, Sandro, Procopio, Giuseppe, Fornarini, Giuseppe, De Giorgi, Ugo, Russo, Antonio, Francini, Edoardo
Publicado 2023